Indeed, the generation of genetically engineered mice exhibiting varying amounts of VAV2 catalytic activity has demonstrated that the inhibition of the GEF activity prevents the generation of skin tumors in vivo [46]. The gene discussed is VAV2; the disease is skin neoplasm.